Glucagon-like peptide-1 preserves non-alcoholic fatty liver disease through inhibition of the endoplasmic reticulum stress-associated pathway

Effects of glucagon-like peptide-1 receptor agonists on non-alcoholic fatty liver disease and inflammation

(2014) Xing-Chun Wang   WORLD JOURNAL OF GASTROENTEROLOGY

GLP-1 analogue prevents NAFLD in ApoE KO mice with diet and Acrp30 knockdown by inhibiting c-JNK

(2013) Lili Zhang et al.   LIVER INTERNATIONAL

Role of ERp46 in β-cell lipoapoptosis through endoplasmic reticulum stress pathway as well as the protective effect of exendin-4

(2012) Dan-Ling Chen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Downregulation of chemerin and alleviation of endoplasmic reticulum stress by metformin in adipose tissue of rats

(2012) Lina Pei et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Nonalcoholic fatty liver disease: The hepatic metabolic syndrome

(2012) Jeni Page ACNP-BC   Journal of the American Academy of Nurse Practitioners

Exendin-4, a glucagon-like peptide-1 receptor agonist, inhibits cell apoptosis induced by lipotoxicity in pancreatic β-cell line

(2012) Qian Wei et al.   PEPTIDES

Exendin-4 Improves Steatohepatitis by Increasing Sirt1 Expression in High-Fat Diet-Induced Obese C57BL/6J Mice

(2012) Jinmi Lee et al.   PLoS One

Nonalcoholic steatohepatitis

(2011) Jörn M. Schattenberg et al.   CURRENT OPINION IN LIPIDOLOGY

Current therapeutic strategies in non-alcoholic fatty liver disease

(2011) J. K. Dowman et al.   DIABETES OBESITY & METABOLISM

The human glucagon-like peptide-1 analogue liraglutide preserves pancreatic beta cells via regulation of cell kinetics and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

(2011) M. Shimoda et al.   DIABETOLOGIA

Glucagon-like peptide-1 receptor activation stimulates hepatic lipid oxidation and restores hepatic signalling alteration induced by a high-fat diet in nonalcoholic steatohepatitis

(2011) Gianluca Svegliati-Baroni et al.   LIVER INTERNATIONAL

The Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation

(2011) P. Walter et al.   SCIENCE

Review article: current management of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis

(2010) Z. M. YOUNOSSI   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

ERp46 binds to AdipoR1, but not AdipoR2, and modulates adiponectin signalling

(2010) Hayley K. Charlton et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Endoplasmic Reticulum Stress and the Inflammatory Basis of Metabolic Disease

(2010) Gökhan S. Hotamisligil   CELL

Glucagon-like peptide-1 receptor is present on human hepatocytes and has a direct role in decreasing hepatic steatosis in vitro by modulating elements of the insulin signaling pathway

(2010) Nitika Arora Gupta et al.   HEPATOLOGY

Glucagon-like peptide-1 reduces hepatic lipogenesis via activation of AMP-activated protein kinase

(2010) Shani Ben-Shlomo et al.   JOURNAL OF HEPATOLOGY

Human Prion Protein Mutants with Deleted and Inserted Octarepeats Undergo Different Pathways to Trigger Cell Apoptosis

(2010) Kun Xu et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

The challenge of developing novel pharmacological therapies for non-alcoholic steatohepatitis

(2010) Detlef Schuppan et al.   LIVER INTERNATIONAL

ERp46 is reduced by high glucose and regulates insulin content in pancreatic β-cells

(2009) Avra Alberti et al.   AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM

Liver cirrhosis

(2008) Detlef Schuppan et al.   LANCET

Cell death and endoplasmic reticulum stress: disease relevance and therapeutic opportunities

(2008) Inki Kim et al.   NATURE REVIEWS DRUG DISCOVERY